How is mononucleosis (mono) diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Mononucleosis is Tested For

Start with a complete blood count with differential and a rapid heterophile antibody test (Monospot), but if the heterophile test is negative and clinical suspicion remains high, proceed directly to EBV-specific antibody testing with VCA IgM, VCA IgG, and EBNA antibodies. 1

Initial Testing Strategy

  • Order a CBC with differential to look for lymphocytosis (≥50% lymphocytes) and atypical lymphocytes (≥10% of total lymphocyte count), which strongly support the diagnosis 1, 2, 3
  • Perform a rapid heterophile antibody test (Monospot) as the first-line serologic test, which has 86% sensitivity and 99% specificity 1, 4
  • The heterophile antibody becomes detectable between days 6-10 after symptom onset and peaks during weeks 2-3 of illness 1

Critical Limitations You Must Know

  • False-negative heterophile tests occur in approximately 10% of patients and are especially common in children younger than 10 years 1, 4
  • In children under 10 years, skip the heterophile test entirely and proceed directly to EBV-specific antibodies 1
  • False-positive results can occur with leukemia, pancreatic carcinoma, viral hepatitis, and CMV infection 1
  • Early in infection (first week), heterophile tests are commonly negative even in true cases 3

EBV-Specific Antibody Panel (When Heterophile is Negative)

Order all three tests together to properly time the infection: 1

  • VCA IgM: Indicates acute/recent infection when positive 1, 5
  • VCA IgG: Develops rapidly in acute infection 1, 5
  • EBNA antibodies: Critical for timing—absent in acute infection, present in past infection 1, 5

Interpreting EBV Antibody Results

Primary acute EBV infection (infectious mononucleosis) is diagnosed when: 1, 5

  • VCA IgM is positive
  • EBNA antibodies are absent
  • VCA IgG may be positive or negative

Past infection (not acute mono) is indicated when: 1, 6

  • EBNA antibodies are present
  • VCA IgM is negative
  • VCA IgG is positive

EBNA antibodies develop 1-2 months after primary infection and persist for life, so their presence rules out acute infection 1

Common Pitfalls to Avoid

  • Do not rely solely on heterophile testing in children under 10 years—proceed directly to EBV-specific antibodies 1
  • Do not order EBV testing from throat swabs—EBV persists in throat secretions for weeks to months after infection and does not confirm acute infection 1
  • Do not assume a positive VCA IgG alone means acute infection—it indicates past infection unless accompanied by positive IgM and negative EBNA 7, 6
  • Consider alternative diagnoses including CMV, adenovirus, HIV, and Toxoplasma gondii when evaluating mononucleosis-like illness 1, 3

Special Populations

  • Immunocompromised patients: Use quantitative EBV viral load testing by nucleic acid amplification for suspected EBV-associated lymphoproliferative disease 1
  • Post-transplant patients: Require EBV DNA surveillance due to high risk of lymphoproliferative disease 1

References

Guideline

Diagnosing Infectious Mononucleosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Infectious Mononucleosis: An Updated Review.

Current pediatric reviews, 2024

Research

Epstein-Barr virus infectious mononucleosis.

American family physician, 2004

Guideline

Serologic Interpretation of Epstein-Barr Virus Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Epstein-Barr Virus Infection Diagnosis and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.